Atlas Trials

Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients

Clinical trial NCT04072198 · COMPLETED

Trial details

NCT number
NCT04072198
Sponsor
Gruppo Oncologico Italiano di Ricerca Clinica
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2019-09-26
Primary completion
2024-08-30
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.